The down‐regulation of SMARCB1, which is observed in HCC tissues relative to adjacent non‐cancerous tissues, is markedly correlated with poorer overall survival for HCC patients and attenuates the sensitivity of HCC cells to sorafenib.66 The gene discussed is SMARCB1; the disease is hepatocellular carcinoma.